Navigation Links
U.S. Patent Office to Issue 11 Patents for Nyxoah's Sleep Apnea Innovative Implant Technology
Date:11/6/2013

BRUSSELS and TEL AVIV, Israel, November 6, 2013 /PRNewswire/ --

Nyxoah, a Belgian-Israeli start-up company that develops a tiny implant for treating sleep apnea and snoring, announced today that the U.S. Patent and Trademark Office (USPTO) is issuing 11 patents for Nyxoah's obstructive sleep apnea technology. The first eight granted patents were published today on the USPTO website. Three more granted patents will be published in the coming weeks.  

     (Photo: http://photos.prnewswire.com/prnh/20131106/649781 )

One out of every five adults over the age of 40 suffers from some degree of obstructive sleep apnea (OSA), which can lead to hypertension, obesity, heart disease and stroke. OSA occurs when the tongue muscle relaxes during sleep, causing the tongue to fall back into the throat, blocking airflow. Nyxoah developed an innovative ultra-small implant that stimulates the tongue muscle to prevent airway blockage. In a short outpatient procedure, a flexible implant the size of a coin and thinner than a few sheets of paper is inserted under a patient's chin with a minimally invasive small incision. Then, before bed each night, the patient places a disposable adhesive battery patch on the underside of the chin, to wirelessly deliver energy to the nerves around the tongue throughout the night, completely preventing airway blockage during the night's sleep.

"The company initiated first-in-man studies, and the fact that we were able to so quickly protect the technology with a portfolio of patents adds significantly to the promise of this company," said Robert Taub, one of Nyxoah's co-founders.  

Dr. Adi Mashiach, Nyxoah's other co-founder, CEO, and inventor elaborated, "There are many groundbreaking aspects to our solution. Being able to stimulate the tongue muscle all night using a small disposable battery patch is a major innovation. And our ability to enable minimally invasive implantation in a quick outpatient setting should open the procedure to a significant percentage of the affected population. The fact that 11 patents were allowed less than a year from the date we filed them, is a testament to the uniqueness of our solution."  

Gerson Panitch, the patent lawyer at Finnegan who developed Nyxoah's IP strategy agrees. "Through careful strategic patent planning, we isolated dozens of critical features, and then pursued those strategies most likely to protect the company's value," Panitch explained. "The patents are designed to work together, providing a web of protection for Nyxoah. Eleven U.S. patents may seem like a lot to receive all at once, but there are many more in the pipeline," Panitch added.

About Nyxoah:

Nyxoah is a clinical-stage medical device start-up company focusing on neuromuscular electrical stimulation treatment of OSA. Nyxoah is headquartered in Brussels, Belgium, with R&D facilities there and in Tel Aviv, Israel. It was founded by Mr. Robert Taub and Dr. Adi Mashiach in 2009.

Media Contact:
Edan Ring
Unik Public Image for Nyxoah
+972-54-6680085
edan@unik.co.il


'/>"/>
SOURCE Nyxoah
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix Announces Private Placement as the Company Continues to Execute its Patent Monetization Program - Spherix accepts $2.0 Million from Investors
2. General Patent Corporation Chairman and CEO Alexander Poltorak Joins Spherix Board Industry veteran and authority on patent law and valuation joins Spherix as director
3. Transposagen Issued Two Key U.S. Patents
4. US Patent Office Issues Patent for VG Life Sciences Peptide for HIV Treatment
5. ViaCyte Granted Over 20 Patents in 2013 Further Establishing the Company as a Leader in the Field of Regenerative Medicine
6. Consolidation, Patent Loses, Weak R&D Productivity Depress ITO Transactions in Life Sciences Segment: Everest Group Annual Report
7. Fingerprint Cards Purchases Key Wireless Patents
8. Convoy Therapeutics Granted Patent for Proprietary SPACE Technology
9. Histogen’s Composition for Hair Growth Receives US Patent
10. AppColl Introduces New Cloud-Based Patent Management Tool
11. Star Scientific Announces Patent Claims to Anatabine Citrate to be Granted by PTO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... FireflySci, Inc ... Founded in late 2014, FireflySci had the goal of bringing their powerful cuvette ... continues to shape the path that FireflySci is going on as they add yet ...
(Date:2/23/2017)... and NEW YORK , ... Lumeon , a leading digital health company, ... a provider of telemedicine and remote patient monitoring, ... for telemedicine reimbursements.  DN Telehealth ... patients, in real-time, extending consultations beyond a physical ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced today ... two key immunotherapy technologies from the University of ... a method to monitor a patient for response ... and CTLA-4.  The second license extends the technology ... is likely to have an immune-related adverse event ...
(Date:2/23/2017)... San Antonio, TX (PRWEB) , ... February 23, ... ... and Drug Administration (FDA) de novo clearance to begin marketing the SPEAC® System, ... is indicated for adults at home or in healthcare facilities during periods of ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
(Date:2/8/2017)... 2017 Report Highlights ... The global synthetic-biology market reached nearly ... 2021, growing at a compound annual growth rate (CAGR) of ... the global markets for synthetic biology. - Analyses of global ... projections of compound annual growth rates (CAGRs) through 2021. - ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
Breaking Biology News(10 mins):